These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15981554)

  • 21. Overview: drug eluting stents.
    Dauerman HL
    Coron Artery Dis; 2006 Dec; 17(8):657-9. PubMed ID: 17119372
    [No Abstract]   [Full Text] [Related]  

  • 22. Failure to retrieve undeployed paclitaxel-eluting coronary stents.
    Schrale R; Ormerod O
    Am J Cardiol; 2006 Aug; 98(3):426. PubMed ID: 16860042
    [No Abstract]   [Full Text] [Related]  

  • 23. Stent thrombosis after sirolimus- and paclitaxel-eluting stent implantation in daily clinical practice: analysis of a single center registry.
    Trabattoni D; Fabbiocchi F; Montorsi P; Ravagnani P; Galli S; Teruzzi G; Calligaris G; De Martini S; Bartorelli AL
    Catheter Cardiovasc Interv; 2007 Sep; 70(3):415-21. PubMed ID: 17722020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is sirolimus better than paclitaxel? A review of the comparative data on drug-eluting stents.
    Corbett SJ; Babic R; Cosgrave J; Sangiorgi GM; Colombo A
    Cardiovasc Revasc Med; 2006; 7(3):159-64. PubMed ID: 16945823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiographic and intravascular ultrasound study of the effects of overlapping sirolimus- and paclitaxel-eluting stents: comparison with same drug-eluting overlapping stents.
    Kang WC; Oh KJ; Han SH; Ahn TH; Chung WJ; Shin MS; Koh KK; Choi IS; Shin EK
    Int J Cardiol; 2007 Dec; 123(1):12-7. PubMed ID: 17289176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcome following aleatory implantation of paclitaxel-eluting or sirolimus-eluting stents in complex coronary lesions.
    Cosgrave J; Agostoni P; Ge L; Iakovou I; Chieffo A; Biondi-Zoccai GG; Sangiorgi GM; Montorfano M; Michev I; Airoldi F; Carlino M; Corvaja N; Bonizzoni E; Colombo A
    Am J Cardiol; 2005 Dec; 96(12):1663-8. PubMed ID: 16360354
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug coated stents for carotid intervention.
    Tepe G; Schmehl J; Claussen CD; Ernemann U; Pereira P; Duda SH
    J Cardiovasc Surg (Torino); 2005 Jun; 46(3):249-59. PubMed ID: 15956922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycophenolic acid-eluting stent and the ABC's of stent-based immunosuppressive therapies for the prevention of restenosis.
    Carter AJ
    Catheter Cardiovasc Interv; 2005 Dec; 66(4):496-8. PubMed ID: 16283681
    [No Abstract]   [Full Text] [Related]  

  • 29. The paclitaxel-eluting stent in percutaneous coronary intervention: Part II. Comparison with the sirolimus-eluting stent, economics, and unanswered questions.
    Ray GM; Nawarskas JJ; Frishman WH
    Cardiol Rev; 2006; 14(3):143-50. PubMed ID: 16628023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-eluting stent: the emerging technique for the prevention of restenosis.
    Sheiban I; Carrieri L; Catuzzo B; Destefanis P; Oliaro E; Moretti C; Trevi GP
    Minerva Cardioangiol; 2002 Oct; 50(5):443-53. PubMed ID: 12384626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study.
    Rittger H; Brachmann J; Sinha AM; Waliszewski M; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Breithardt OA; Schmidt M; Zimmermann S; Lonke S; von Cranach M; Nguyen TV; Daniel WG; Wöhrle J
    J Am Coll Cardiol; 2012 Apr; 59(15):1377-82. PubMed ID: 22386286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is late luminal loss an accurate predictor of the clinical effectiveness of drug-eluting stents in the coronary arteries?
    Agostoni P; Valgimigli M; Abbate A; Cosgrave J; Pilati M; Biondi-Zoccai GG
    Am J Cardiol; 2006 Mar; 97(5):603-5. PubMed ID: 16490421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct stenting with TAXUS stents seems to be as safe and effective as with predilatation. A post hoc analysis of TAXUS II.
    Silber S; Hamburger J; Grube E; Pfisterer M; Belardi J; Webb J; Zmudka K; Nienaber C; Hauptman K; Rutsch W; Dawkins K; Drzewiecki J; Koglin J; Colombo A
    Herz; 2004 Mar; 29(2):171-80. PubMed ID: 15057438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study.
    Mehilli J; Byrne RA; Tiroch K; Pinieck S; Schulz S; Kufner S; Massberg S; Laugwitz KL; Schömig A; Kastrati A;
    J Am Coll Cardiol; 2010 Jun; 55(24):2710-6. PubMed ID: 20226618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized comparison of paclitaxel-eluting stents versus bare-metal stents for treatment of unprotected left main coronary artery stenosis.
    Erglis A; Narbute I; Kumsars I; Jegere S; Mintale I; Zakke I; Strazdins U; Saltups A
    J Am Coll Cardiol; 2007 Aug; 50(6):491-7. PubMed ID: 17678730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of platelet glycoprotein IIb/IIIa Inhibition on the paclitaxel-eluting stent in patients with stable or unstable angina pectoris or provocable myocardial ischemia (a TAXUS IV substudy).
    Teirstein PS; Kao J; Watkins M; Tannenbaum MA; Laufer N; Chang M; Mehran R; Dangas G; Russell ME; Ellis SG; Stone GW
    Am J Cardiol; 2005 Aug; 96(4):500-5. PubMed ID: 16098300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The present and future of drug-eluting stents.
    Indolfi C; Mongiardo A; Spaccarotella C; Ferraro A; Torella D
    Ital Heart J; 2005 Jun; 6(6):498-506. PubMed ID: 16008155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of coronary culprit lesion calcium in patients undergoing paclitaxel-eluting stent implantation (a TAXUS-IV sub study).
    Moussa I; Ellis SG; Jones M; Kereiakes DJ; McMartin D; Rutherford B; Mehran R; Collins M; Leon MB; Popma JJ; Russell ME; Stone GW
    Am J Cardiol; 2005 Nov; 96(9):1242-7. PubMed ID: 16253590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.
    Adriaenssens T; Dens J; Ughi G; Coosemans M; Onsea K; Dubois C; Sinnaeve P; Vrolix M; Desmet W
    EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis.
    Bavry AA; Kumbhani DJ; Helton TJ; Bhatt DL
    J Am Coll Cardiol; 2005 Mar; 45(6):941-6. PubMed ID: 15766833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.